E-LIB Suche - Ergebnisse für: Tyekucheva, S.

1

Multiplexed high-throughput immune cell imaging in patients..:

Rusakiewicz, S. ; Tyekucheva, S. ; Tissot-Renaud, S....
European Journal of Cancer. 200 (2024) - p. 113535 , 2024

Link: https://doi.org/10.1016/..

2

5‐YEAR (Y) FOLLOW‐UP OF A PHASE 2 STUDY OF IBRUTINIB PLUS F..:

Ahn, I. E. ; Brander, D. M. ; Ren, Y....
Hematological Oncology. 41 (2023) S2 - p. 231-233 , 2023

Link: https://doi.org/10.1002/..

3

Initial results of a multicenter phase 2 study of venetocla..:

Davids, M. S. ; Rogers, K. A. ; Jain, N....
Hematological Oncology. 41 (2023) S2 - p. 466-468 , 2023

Link: https://doi.org/10.1002/..

4

P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR..:

Ryan, C. ; Brander, D. ; Barr, P....
HemaSphere. 6 (2022) - p. 572-573 , 2022

Link: https://doi.org/10.1097/..

5

P599: RARE GERMLINE VARIANTS IN ATM INFLUENCE THE PATHOGENE..:

Lampson, B. L. ; Gupta, A. ; Tyekucheva, S....
HemaSphere. 6 (2022) - p. 498-499 , 2022

Link: https://doi.org/10.1097/..

6

INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLA..:

Davids, M.S. ; Thompson, P.A. ; Rogers, K.A....
Hematological Oncology. 37 (2019) S2 - p. 134-135 , 2019

Link: https://doi.org/10.1002/..

7

Molecular differences in transition zone and peripheral zon..:

Sinnott, J. A. ; Rider, J. R. ; Carlsson, J....
Carcinogenesis. 36 (2015) 6 - p. 632-638 , 2015

Link: https://doi.org/10.1093/..

8

Extent, impact, and mitigation of batch effects in tumor bi..:

Stopsack K. H ; Tyekucheva S ; Wang M...
info:eu-repo/semantics/altIdentifier/pmid/34939926. , 2021

Link: http://hdl.handle.net/11..

9

Transcriptome Deconvolution of Heterogeneous Tumor Samples ..:

Wang, Z ; Cao, S ; Morris, J...
doi:10.1016/j.isci.2018.10.028. , 2019

Link: https://doi.org/10.1016/..

10

Inhibition of de novo lipogenesis targets androgen receptor..:

Zadra, G ; Ribeiro, C.F ; Chetta, P...
http://purl.org/au-research/grants/arc/FT130101004. , 2019

Link: http://hdl.handle.net/24..

11

P599: RARE GERMLINE VARIANTS IN ATM INFLUENCE THE PATHOGENE..:

B. L. Lampson ; A. Gupta ; S. Tyekucheva...
http://journals.lww.com/10.1097/01.HS9.0000845284.07094.b9. , 2022

Link: https://doi.org/10.1097/..

12

P674: UPDATED RESULTS OF A PHASE 1B STUDY OF IBRUTINIB (IBR..:

C. Ryan ; D. Brander ; P. Barr...
http://journals.lww.com/10.1097/01.HS9.0000845580.45096.48. , 2022

Link: https://doi.org/10.1097/..

13

Five-year follow-up of a phase 2 study of ibrutinib plus fl..:

Ahn, Inhye E. ; Brander, Danielle M. ; Ren, Yue...
Blood Advances. 8 (2024) 4 - p. 832-841 , 2024

Link: https://doi.org/10.1182/..

14

A phase 1b study of ibrutinib in combination with obinutuzu..:

Ryan, Christine E. ; Brander, Danielle M. ; Barr, Paul M....
Leukemia. 37 (2023) 4 - p. 835-842 , 2023

Link: https://doi.org/10.1038/..

15

Circulating Th17 T cells at treatment onset predict autoimm..:

Gadi, Deepti ; Martindale, Stephen P. ; Chiu, Pui Yan...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..